Stock Events

Stock Events

Tastemaker Acquisition

$10.78

6

+$0+0% Monday 20:00

Statistics

Day High

10.78

Day Low

-

52W High

11

52W Low

9.94

Volume

0

Avg. Volume

5,198

Mkt Cap

31.55M

P/E Ratio

0

Dividend Yield

-

Dividend

-

Earnings

6NovExpected

Q2 2021

Q3 2021

Q4 2021

Q1 2022

Q2 2022

Q3 2022

Q3 2023

-0.11

-0.02

0.08

0.17

Expected EPS

N/A

Actual EPS

N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow TMKR. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

Evolus directly competes with AEON Biopharma in the aesthetic and therapeutic botulinum toxin products sector.

Revance Therapeutics

Revance Therapeutics competes in the development of botulinum toxin products for aesthetic and therapeutic uses, similar to AEON Biopharma.

AbbVie, through its acquisition of Allergan, competes in the botulinum toxin market, particularly in therapeutic areas.

Merck & Co., Inc. competes in the broader pharmaceuticals market, including areas that overlap with AEON Biopharma's focus.

Pfizer competes in the pharmaceuticals sector, including development of products that could compete with AEON Biopharma's offerings.

Bristol-Myers Squibb

Bristol Myers Squibb competes in the pharmaceutical industry, potentially overlapping with AEON Biopharma's therapeutic areas.

GlaxoSmithKline competes in the pharmaceutical and healthcare sector, including areas relevant to AEON Biopharma's market.

Novartis competes in the global healthcare market, including in therapeutic areas that may overlap with AEON Biopharma's focus.

Johnson & Johnson

Johnson & Johnson competes across the healthcare spectrum, including pharmaceuticals that could compete with AEON Biopharma's products.

About

Tastemaker Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or business combination with one or more businesses. It intends to focus on companies in the restaurant, hospitality, and related technology and services sectors. The company was incorporated in 2020 and is based in New York, New York.

Show more...

CEO

Country

US

ISIN

US8765451047

Listings